cbdMD (YCBD) Free Cash Flow (2016 - 2025)
cbdMD (YCBD) posted Free Cash Flow of -$977266.0 for Q4 2025, down 301.25% sequentially from -$243553.0 in Q3 2025, and down 102.61% YoY from $37.4 million in Q4 2024.
cbdMD (YCBD) Free Cash Flow (2016 - 2025) Analysis & Trends
cbdMD has reported Free Cash Flow for 10 years, with the latest figure at -$977266.0 in Q4 2025.
- Quarterly Free Cash Flow fell 102.61% year-over-year to -$977266.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.1 million (down 190.14% YoY) and the FY2025 annual result came in at -$1.6 million, down 201.5% from the prior year.
- Free Cash Flow eased to -$977266.0 in Q4 2025 per YCBD's latest filing, from -$243553.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $289779.0 in Q2 2024 and troughed at -$5.7 million in Q4 2021.
- A 5-year average of -$1.8 million and a median of -$841470.5 in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2024: Free Cash Flow tumbled 3122.64% in 2021, then soared 184.49% in 2024.
- Over 5 years, Free Cash Flow stood at -$5.7 million in 2021, then surged by 60.67% to -$2.2 million in 2022, then jumped by 87.04% to -$290515.0 in 2023, then sank by 66.03% to -$482336.0 in 2024, then tumbled by 102.61% to -$977266.0 in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$977266.0, -$243553.0, and -$705675.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -977,266.00 |
| Dec 31, 2025 | -977,266.00 |
| Sep 30, 2025 | -243,553.00 |
| Sep 30, 2025 | -243,553.00 |
| Jun 30, 2025 | -705,675.00 |
| Jun 30, 2025 | -705,675.00 |
| Mar 31, 2025 | -204,983.00 |
| Mar 31, 2025 | -204,983.00 |
| Dec 31, 2024 | -482,336.00 |
| Dec 31, 2024 | -482,336.00 |
| Sep 30, 2024 | 157,377.00 |
| Sep 30, 2024 | 157,377.00 |
| Jun 30, 2024 | 289,779.00 |
| Jun 30, 2024 | 289,779.00 |
| Mar 31, 2024 | -699,448.00 |
| Mar 31, 2024 | -699,448.00 |
| Dec 31, 2023 | -290,515.00 |
| Dec 31, 2023 | -290,515.00 |
| Sep 30, 2023 | -383,681.00 |
| Sep 30, 2023 | -383,681.00 |